Stephen Davis, CEO: Acadia Pharmaceuticals ACAD Sell · Filed 24/03/27

Trade details

Type: Insider sale
Amount: $317,080.6
Shares · price: 17,714 sh · $17.90 a share
Held after: 118,842 sh
Stock: Acadia Pharmaceuticals ACAD
Person: Stephen DavisCEO
Trade date: 24/03/27
Filed: 24/03/27
Days to filing: 0 days

Sold 13.0% of holdings

Share of holding sold: 13.0%

Acadia Pharmaceuticals trades, last 26 weeks

What else happened in Acadia Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/02/26~24/04/26

Stephen Davis's recent trades

Stephen DavisCEO
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$485.1K
31,747 sh
$485.1K
Filed 24/08/20
Traded 24/08/19
Stephen DavisCEO
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$193.6K
11,427 sh
$193.6K
Filed 24/05/03
Traded 24/05/02
Stephen DavisCEO
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$316.6K
17,716 sh
$316.6K
Filed 24/04/09
Traded 24/04/08
Stephen DavisCEO
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$158.3K
8,858 sh
$158.3K
Filed 24/04/09
Traded 24/04/08
Stephen DavisCEO
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$137.6K
5,577 sh
$137.6K
Filed 24/02/27
Traded 24/02/26